Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 02, 2023

BUY
$0.35 - $3.28 $146,755 - $1.38 Million
419,302 New
419,302 $146,000
Q3 2022

Nov 10, 2022

SELL
$2.66 - $3.97 $4,037 - $6,026
-1,518 Reduced 12.28%
10,843 $40,000
Q2 2022

Aug 11, 2022

SELL
$2.42 - $4.05 $197,447 - $330,439
-81,590 Reduced 86.84%
12,361 $35,000
Q1 2022

May 12, 2022

SELL
$3.45 - $5.83 $1,466 - $2,477
-425 Reduced 0.45%
93,951 $378,000
Q4 2021

Feb 11, 2022

BUY
$4.89 - $7.59 $8,479 - $13,161
1,734 Added 1.87%
94,376 $502,000
Q3 2021

Nov 12, 2021

BUY
$5.18 - $7.41 $424,785 - $607,657
82,005 Added 770.94%
92,642 $659,000
Q2 2021

Aug 12, 2021

BUY
$3.94 - $6.75 $41,909 - $71,799
10,637 New
10,637 $72,000

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.